Phathom Pharmaceuticals, Inc. - Common Stock — 재무제표 (NASDAQ:PHAT) | MetaTrader

전체 차트 열기 Full chart

뉴스

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Guggenheim, Phathom 목표 주가 25달러로 상향…매출 호조에 힘입어

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel, Phathom에 ’매수’ 의견 유지, 목표 주가 28달러 유지

Stifel reiterates Buy on Phathom stock, keeps $28 price target